Walvax BioTech (300142) — Financial Flexibility Index
Walvax BioTech (300142) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥182.25 Million (operating CF CN¥-33.52 Million minus capex CN¥215.77 Million) represents 0% of total liabilities (CN¥2.31 Billion). Check cash flow reinvestment rate of Walvax BioTech to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Walvax BioTech Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Walvax BioTech across 19 annual periods. For the full cash flow conversion analysis, see Walvax BioTech (300142) cash flow conversion.
Annual Financial Flexibility Index for Walvax BioTech (2007–2025)
Year-by-year free cash flow to debt coverage for Walvax BioTech. Explore how well can Walvax BioTech service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.44x | CN¥1.00 Billion | CN¥494.37 Million | CN¥2.26 Billion | ▼ -9.8% |
| 2024 | 0.49x | CN¥1.59 Billion | CN¥1.04 Billion | CN¥3.22 Billion | ▼ -0.5% |
| 2023 | 0.50x | CN¥2.08 Billion | CN¥1.13 Billion | CN¥4.19 Billion | ▼ -6.0% |
| 2022 | 0.53x | CN¥2.29 Billion | CN¥1.20 Billion | CN¥4.35 Billion | ▲ +7.2% |
| 2021 | 0.49x | CN¥1.81 Billion | CN¥705.28 Million | CN¥3.68 Billion | ▲ +69.9% |
| 2020 | 0.29x | CN¥521.32 Million | CN¥114.19 Million | CN¥1.80 Billion | ▼ -5.4% |
| 2019 | 0.31x | CN¥413.84 Million | CN¥62.02 Million | CN¥1.35 Billion | ▲ +274.5% |
| 2018 | 0.08x | CN¥162.09 Million | CN¥-65.23 Million | CN¥1.98 Billion | ▼ -40.9% |
| 2017 | 0.14x | CN¥320.93 Million | CN¥-10.13 Million | CN¥2.32 Billion | ▲ +141.8% |
| 2016 | 0.06x | CN¥160.30 Million | CN¥-89.94 Million | CN¥2.80 Billion | ▼ -5.2% |
| 2015 | 0.06x | CN¥195.34 Million | CN¥-69.41 Million | CN¥3.23 Billion | ▼ -4.6% |
| 2014 | 0.06x | CN¥174.46 Million | CN¥-65.93 Million | CN¥2.76 Billion | ▼ -24.5% |
| 2013 | 0.08x | CN¥267.94 Million | CN¥-121.73 Million | CN¥3.20 Billion | ▼ -75.3% |
| 2012 | 0.34x | CN¥434.25 Million | CN¥78.38 Million | CN¥1.28 Billion | ▼ -65.6% |
| 2011 | 0.99x | CN¥289.54 Million | CN¥91.98 Million | CN¥293.62 Million | ▲ +70.7% |
| 2010 | 0.58x | CN¥251.53 Million | CN¥86.71 Million | CN¥435.52 Million | ▼ -22.2% |
| 2009 | 0.74x | CN¥156.94 Million | CN¥82.18 Million | CN¥211.43 Million | ▲ +537.6% |
| 2008 | 0.12x | CN¥23.70 Million | CN¥-5.69 Million | CN¥203.54 Million | ▼ -53.6% |
| 2007 | 0.25x | CN¥50.10 Million | CN¥31.85 Million | CN¥199.86 Million | — |